Maze Therapeutics MAZE
NASDAQ MAZE
$32.44 +2.74 (+9.24%)
As of: Oct 20, 2026 · 3:59 PM EDT

Maze Therapeutics (MAZE) Revenue (2024 - 2026)

Updated

Maze Therapeutics' Revenue came in at $20 million for Q1 2026.

Analysis

Maze Therapeutics (MAZE) Revenue (2024 - 2026) Analysis & Trends

For FY2024, Maze Therapeutics' Revenue was $167.5 million.

  • The Q1 2026 figure represents the highest quarterly Revenue since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 25.31 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 16.99 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 15.38 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 7.80 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 15.03 Bn
10 Maze Therapeutics 1.91 Bn 417.43 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 20.00 Mn
Sep 30, 2024 2.50 Mn
Jun 30, 2024 165.00 Mn
API Access

Maze Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=MAZE&period=max&api_key=YOUR_API_KEY